This inventor holds 2 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Ritsuko Katahira: Innovator in Antitumor Compounds
Introduction
Ritsuko Katahira is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor activity. With a total of 2 patents to her name, her work is recognized for its potential impact on cancer treatment.
Latest Patents
Among her latest inventions are the UCK14 compounds, which are characterized by their antitumor properties. These compounds are represented by a specific chemical formula, wherein R¹ can be hydrogen or a particular alkyl group, and R² and R³ can either form a specific bond or exist independently as hydrogen. Another notable compound she has developed is UCH9, which also contributes to her innovative portfolio.
Career Highlights
Ritsuko Katahira is currently associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. Her work at this institution has allowed her to focus on the development of novel therapeutic agents that can address critical health challenges.
Collaborations
Throughout her career, Ritsuko has collaborated with esteemed colleagues such as Yoshinori Yamashita and Tamio Mizukami. These partnerships have fostered a collaborative environment that enhances the research and development of innovative compounds.
Conclusion
Ritsuko Katahira stands out as a dedicated inventor whose work in antitumor compounds holds promise for future medical advancements. Her contributions to the field are invaluable, and her ongoing research continues to inspire innovation in cancer treatment.